엘레바이 랩스(ELAB)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.80 (+1.69%), 시가총액 $0.01B, 52주 최저~최고 $0.71 ~ $14.00.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and pro
엘레바이 랩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
엘레바이 랩스의 현재 주가는 $4.80 (+1.69%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
엘레바이 랩스의 시가총액은 약 $0.01B입니다.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and